Search Results 1251-1260 of 3913 for Solid
... solid organ transplantation - Patient must not have active tuberculosis - Patient must not have history of idiopathic pulmonary fibrosis, pneumonitis ...
Criteria in Solid Tumors (RECIST) version 1.1, computed tomography (CT) scans or magnetic resonance imaging (MRI)s used to assess the measurable disease ...
This fellowship therefore provides a rich and solid knowledge base for independent practice once the trainees are 'unleashed' into the real world." 2013 ...
Patients has a past or current diagnosis of invasive cancer (this does not include basal cell or squamous cell skin cancers). · Patient has had a solid organ ...
The purpose of this study is to evaluate the safety, tolerability, and preliminary effectiveness of HMPL-306 in advanced or metastatic solid tumors with IDH ...
Measurable disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST 1.1, see Section 9); Karnofsky performance Status ≥ 70% (Section 15) ...
At least one measurable lesion according to Response Evaluation Criteria in Solid Tumors (RECIST) 1.1. Eastern Cooperative Oncology Group (ECOG) performance ...
Patients with measurable or evaluable disease according to the response evaluation criteria in solid tumors; Patients eligible for second-line therapy after ...
History of malignancy within the last 5 years prior to baseline, including solid tumors, hematologic malignancies and in situ carcinoma (except basal cell ...
Success of cancer immunotherapy is limited by the ability of solid tumors to evade local and systemic antitumoral immune responses. Several mechanisms of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.